Coya Therapeutics, Inc.
COYA
$5.26
$0.040.77%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -12.88% | -51.30% | |||
| Gross Profit | 12.97% | -94.93% | |||
| SG&A Expenses | -3.67% | 6.28% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.27% | -33.19% | |||
| Operating Income | 8.31% | -37.52% | |||
| Income Before Tax | 9.58% | -39.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.49% | -39.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.49% | -39.07% | |||
| EBIT | 8.31% | -37.52% | |||
| EBITDA | 8.32% | -37.60% | |||
| EPS Basic | 32.51% | -36.26% | |||
| Normalized Basic EPS | 15.87% | -36.22% | |||
| EPS Diluted | 32.51% | -36.26% | |||
| Normalized Diluted EPS | 15.87% | -36.22% | |||
| Average Basic Shares Outstanding | 7.46% | 2.05% | |||
| Average Diluted Shares Outstanding | 7.46% | 2.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||